Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studies

Background: Virtually all patients with extensive-stage small cell lung cancer (SCLC) develop resistance to firstline platinum-based chemoimmunotherapy and experience relapse. Second-line therapy is therefore an integral part of the treatment paradigm. Methods: Evidence was reviewed for key sec...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Leonid Shunyakov, Firas B Badin, Judith Hafer, David König, Patrizia Froesch, Laurent Greillier
Format:	Artigo
Język:	Inglês
Wydane:	BioExcel Publishing Ltd 2025-10-01
Seria:	Drugs in Context
Hasła przedmiotowe:	extensive-stage small cell lung cancer lurbinectedin platinum rechallenge second-line chemotherapy topotecan
Dostęp online:	https://www.drugsincontext.com/place-in-therapy-of-key-treatments-for-platinum-sensitive-relapsed-extensive-stage-small-cell-lung-cancer-with-a-focus-on-lurbinectedin-a-narrative-review-with-case-studies/
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!